Results 91 to 100 of about 34,871 (236)
Movement Disorders, EarlyView.Abstract Background Differentiating progressive supranuclear palsy (PSP) from Parkinson's disease (PD) can be clinically challenging. In the neuroimaging field, radiomics has emerged as a promising approach to capture subtle microstructural and textural image alterations, improving differential diagnoses.
Chiara Camastra +8 more
wiley +1 more source
Radiopharmaceuticals used in myocardial perfusion scintigraphy [PDF]
, 2017 Three radiopharmaceuticals are in routine clinical use in myocardial perfusion scintigraphy: thallium-201 (201Tl) as thallous chloride, technetium-99m (99mTc) sestamibi, and 99mTc tetrofosmin.
Nikant Sabharwal +2 more
core +1 more source
Research Progress of 64Cu-Radiopharmaceuticals in Clinical Trial for Tumor Diagnosis
Journal of Isotopes, 2021 Positron computed emission tomography (PET) is an important diagnosis and imaging tool for nuclear medicine with the advantages of high sensitivity, resolution, and safety.
ZHAO Hailong;LI Hongyu
doaj
Long‐Duration Response to Levodopa in the PPMI‐Cohort
Movement Disorders, EarlyView.Abstract Background Treatment of Parkinson's disease (PD) with levodopa results in a sustained reduction of symptoms. Although the plasma half‐life of levodopa is short, it elicits a lasting effect, the long‐duration levodopa response (LDR). A decrease in LDR as PD progresses has been linked to motor complications, but long‐term data on the LDR and its
Nils Schnalke +3 more
wiley +1 more source
Can radiopharmaceuticals be delivered by quantum dots? [PDF]
Radiopharmaceuticals have become integral in modern med-ical imaging and targeted therapy, particularly in oncology,neurology, and cardiology. These drugs combine radioactiveisotopes with pharmaceutical agents, enabling highly specificdiagnostic imaging ...
Ilem Ozdemir, Derya +1 more
core +1 more source
Регуляторные исследования и экспертиза лекарственных средствINTRODUCTION. Currently in the Russian Federation and the Eurasian Economic Union (EAEU), the conduct of non-clinical studies of radiopharmaceuticals is regulated by general guidelines on non-clinical studies, which are applicable to multiple groups of ...
O. E. Klementyeva +5 more
doaj +1 more source
2D van der Waals System Integrated with Targeting Radio‐Diagnostic and Imaging Functions
Small, EarlyView.Layered double hydroxide (LDH) nanoplates were engineered for tumor‐targeted imaging and therapy. By exploiting folate receptor (FR) expression levels, the system achieves selective tumor accumulation and high‐resolution dual PET/fluorescence (PET/FL) imaging.
Sairan Eom +6 more
wiley +1 more source
Radiopharmaceuticals for the visualization of infectious and inflammatory lesions [PDF]
, 2000 Many radiopharmaceuticals have been introduced for the scintigraphic demonstration of infectious and inflammatory lesions and some of them are currently in clinical use.
Ercan, MT, Kostakoglu, L
core +1 more source
Journal of Medical Imaging and Radiation Oncology, EarlyView.ABSTRACT Introduction Accurate preoperative physiological assessment is critical for high‐risk patients undergoing lung resection to predict postoperative lung function. This study compared quantitative dual‐energy CT (DECT) perfusion with SPECT/CT for lobar perfusion mapping in an at‐risk oncological cohort.
Jack Edward Liu +6 more
wiley +1 more source